Press Releases


Filter: All | Regulatory | Non regulatory

2023

2023-01-31

Correction: the Subscription Price for Realhearts Warrant TO1 is SEK 2.36

2023-01-30

Information on Trading and Exercise of Warrants of Series TO1 in Realheart

2023-01-23

Dr. Ulf Kjellman Strengthens Realheart's Medical Advisory Board

2023-01-10

Realheart Reaches New Milestone With the World’s First Four Chamber Artificial Heart

2022

2022-12-07

Correction: Interim Report 220701-220930

2022-11-18

Interim Report 220701-220930

2022-10-27

Third Animal Implantation Completed - Trials Continue

2022-08-19

Interim Report 220101-220630

2022-07-08

Realheart Successfully Completes Second Animal Implant of its Total Artificial Heart

2022-06-27

Jonas Caspari Bark New CFO at Realheart

2022-06-02

First Animal Trial with Clinical Version Completed

2022-05-27

Realheart’s CEO Presents Blood Results at the ISMCS Conference in Hannover

2022-05-01

Realheart releases the annual report for 2021

2022-04-28

Improved controller for clinical trials results in six-month delay

2022-04-26

Realheart to recruit new CFO

2022-02-24

Christer Norström appointed acting chairman of Realheart

2022-02-21

Realheart Chairman Göran Hellers has died

2022-01-18

Realheart provides clarification on UAE media reports

2021

2021-12-16

Realheart receives an EU grant of 2.5 million euros for its artificial heart

2021-08-31

Realheart prepares listing on Nasdaq First North Growth Market break

2021-03-08

Correction of press release: Dr Ina Laura Perkins new CEO of Realheart

2021-03-08

Dr Ina Laura Perkins new CEO of Realheart

2020

2020-06-11

Realheart signs an important agreement with largest European heart pump manufacturer

2020-01-07

Results from Realheart's latest trial series: The sheep was awakened and able to eat

2019

2019-07-12

Realheart summarizes the spring’s animal trials and tests automatic control

2019-05-29

Realheart uses sheep as animal model and performs fitting trials